Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin and furosemide administration strategies in pediatric nephrotic syndrome
IRCT20120415009475N11Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Feb 2022
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of albumin (human) and furosemide in nephrosis (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Patient weight and Urine sodium level. Started Feb 2022; status: completed.
02
Drugs
albumin (human)furosemide
03
Conditions
nephrosis
Beyond the preview
Go deeper on IRCT20120415009475N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120415009475N11.